
Reset all filters
01 1Bystolic
02 4Bystolic/Byvalson
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 614
2016 Revenue in Millions : 641
Growth (%) : -4
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 586
2017 Revenue in Millions : 614
Growth (%) : -5%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 641
2015 Revenue in Millions : 646
Growth (%) : -1
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 603
2018 Revenue in Millions : 586
Growth (%) : 3
Main Therapeutic Indication : Antihypertensives
Currency : USD
2014 Revenue in Millions :
2013 Revenue in Millions :
Growth (%) :